Researchers have created an effective therapy for chronic pain that reduces pain intensity by focusing on emotional regulation. A new study led by UNSW Sydney and Neuroscience Research Australia ...

Health and Human Services Secretary Robert F. Kennedy Jr. has made some claims about Americans with chronic diseases that should be challenged with critical thinking. (Alex Wong/Getty Images ...

In her new book, “Mind Your Body: A Revolutionary Program to Release Chronic Pain and Anxiety,” the author, podcaster and public speaker shares her method for eliminating not just chronic pain ...

Eleanor Rivera receives funding from the National Institutes of Health. She is affiliated with the National Kidney Foundation and the Department of Veterans Affairs. For a disease afflicting 35.5 ...

I think we’re past the point where I have to explain that chronic pain is not the result of imbalanced humors or a wandering uterus or possession by demons. But for more modern skeptics ...

The loss of stability of the tear film, the accumulation of inflammatory mediators, and the delay in the replacement of cellular elements establish the basis for the formation of the chronic ... and ...

NEW ALBANY, Ind. — A new approach to treating Thygeson’s superficial punctate keratitis, a rare chronic bilateral corneal disorder, could be application of a topical cyclosporine solution.

Superficial phlebitis is a condition where there is inflammation of a vein just under the skin, often in the leg. The term “phlebitis” refers to inflammation of a vein, and “superficial ...

Clinical features such as the size and depth of the stromal infiltrate, the size of the ulcer (measured in millimeter), the presence or absence of a hypopyon (measured in millimeters), pre-existing ...

One of the most severe complications of HSV is herpetic stromal keratitis (HSK), which affects the cornea of the eye and can lead to visual impairment or even blindness. Unfortunately, current ...

95% CI 1.158-1.615), superficial keratitis (HR 1.635, 95% CI 1.306-2.047), and corneal ulcer (HR 2.132, 95% CI 1.515-3.002). Notably, patients taking the second-generation EGFR inhibitor afatinib ...